Jacqueline Nam

448 total citations
22 papers, 310 citations indexed

About

Jacqueline Nam is a scholar working on Rheumatology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jacqueline Nam has authored 22 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 7 papers in Hematology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jacqueline Nam's work include Rheumatoid Arthritis Research and Therapies (21 papers), Systemic Lupus Erythematosus Research (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Jacqueline Nam is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (21 papers), Systemic Lupus Erythematosus Research (7 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). Jacqueline Nam collaborates with scholars based in United Kingdom, Italy and United States. Jacqueline Nam's co-authors include Paul Emery, E. Hensor, Kulveer Mankia, Andrea Di Matteo, Laura Hunt, Leticia Garcia‐Montoya, Maya H Buch, Richard J. Wakefield, Edoardo Cipolletta and John Fitton and has published in prestigious journals such as Annals of Internal Medicine, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Jacqueline Nam

21 papers receiving 310 citations

Peers

Jacqueline Nam
Jacqueline Nam
Citations per year, relative to Jacqueline Nam Jacqueline Nam (= 1×) peers Sylvie Hoang

Countries citing papers authored by Jacqueline Nam

Since Specialization
Citations

This map shows the geographic impact of Jacqueline Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Nam more than expected).

Fields of papers citing papers by Jacqueline Nam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Nam. The network helps show where Jacqueline Nam may publish in the future.

Co-authorship network of co-authors of Jacqueline Nam

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Nam. A scholar is included among the top collaborators of Jacqueline Nam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Nam. Jacqueline Nam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia‐Montoya, Leticia, Jing Kang, Andrea Di Matteo, et al.. (2024). Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study. The Lancet Rheumatology. 6(2). e72–e80. 8 indexed citations
3.
Matteo, Andrea Di, Enrico De Lorenzis, Jacqueline Nam, et al.. (2023). Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction. Lara D. Veeken. 63(8). 2213–2221. 5 indexed citations
4.
Hensor, E., Michelle Wilson, Leticia Garcia‐Montoya, et al.. (2023). Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification. Annals of Internal Medicine. 176(8). 1027–1036. 18 indexed citations
5.
David, Paula, Andrea Di Matteo, Shouvik Dass, et al.. (2023). Poly‐Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes. Arthritis & Rheumatology. 76(4). 510–521. 21 indexed citations
6.
Garcia‐Montoya, Leticia, et al.. (2022). Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study. Arthritis Research & Therapy. 24(1). 26–26. 9 indexed citations
7.
Fitton, John, Andrew Melville, Kamran Naraghi, et al.. (2022). Single-centre experience of refractory rheumatoid arthritis. Rheumatology Advances in Practice. 6(2). rkac057–rkac057. 8 indexed citations
8.
Matteo, Andrea Di, Edoardo Cipolletta, Jacqueline Nam, et al.. (2021). Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum. Lara D. Veeken. 61(8). 3192–3200. 16 indexed citations
9.
Matteo, Andrea Di, Kulveer Mankia, Edoardo Cipolletta, et al.. (2020). Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis. Annals of the Rheumatic Diseases. 79(7). 901–907. 35 indexed citations
10.
Matteo, Andrea Di, Kulveer Mankia, Jacqueline Nam, et al.. (2020). In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis. Lara D. Veeken. 60(7). 3156–3164. 13 indexed citations
11.
Fitton, John, Andrew Melville, Paul Emery, Jacqueline Nam, & Maya H Buch. (2020). Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway. Lara D. Veeken. 60(9). 4048–4054. 28 indexed citations
12.
Mankia, Kulveer, et al.. (2020). P240 Can ultrasound alone predict the need to treat ACPA positive individuals without synovitis?. Lara D. Veeken. 59(Supplement_2). 1 indexed citations
13.
Mankia, Kulveer, Maria Antonietta D’Agostino, Emma Rowbotham, et al.. (2019). MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis. Annals of the Rheumatic Diseases. 78(6). 781–786. 21 indexed citations
14.
Fitton, John, Andrew Melville, Shouvik Dass, et al.. (2019). THU0169 JANUS KINASE INHIBITORSDEMONSTRATE EFFECTIVENESS IN A REAL-WORLD MULTI-BIOLOGIC DMARD REFRACTORY RHEUMATOID ARTHRITIS POPULATION. Annals of the Rheumatic Diseases. 78. 358–359. 2 indexed citations
15.
Mankia, Kulveer, et al.. (2019). THU0072 ULTRASOUND PREDICTS IMMINENT PROGRESSION TO ARTHRITIS IN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS. Annals of the Rheumatic Diseases. 78. 304–305. 4 indexed citations
16.
Fitton, John, Shouvik Dass, Paul Emery, Jacqueline Nam, & Maya H Buch. (2019). 087 Janus kinase inhibitors demonstrate effectiveness in a real-world multi-biologic DMARD refractory rheumatoid arthritis population. Lara D. Veeken. 58(Supplement_3).
17.
Fitton, John, Andrew Melville, Kamran Naraghi, et al.. (2019). FRI0090 SINGLE CENTRE COHORT OF REFRACTORY RHEUMATOID ARTHRITIS ALSO IDENTIFIES A RARE SUBGROUP OF MULTIPLE TARGETED THERAPY CLASS NON-RESPONSE. Annals of the Rheumatic Diseases. 78. 708–708. 1 indexed citations
18.
Hensor, E., Paul McKeigue, Maya H Buch, et al.. (2018). O12 Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis. Lara D. Veeken. 57(suppl_3). 2 indexed citations
19.
Bissell, Lesley-Anne, E. Hensor, Łukasz Kozera, et al.. (2016). Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis—results from the IDEA study. Lara D. Veeken. 55(12). 2181–2190. 24 indexed citations
20.
Nam, Jacqueline, Laura Hunt, E. Hensor, & Paul Emery. (2015). Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms – a cohort study. Annals of the Rheumatic Diseases. 75(8). 1452–1456. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026